Ultragenyx Reports Fourth Quarter and Full Year 2017 Financial Results and Corporate Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Dow, S&P 500 fall, tech steadies to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| WISDOMTREE DEFA EQUITY INCOME FUND (NYSE: DTH) | Delayed: 55.58 -0.07 (0.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $55.65 | 52 Week High | $39.68 | |||
| Open | $55.25 | 52 Week Low | $33.21 | |||
| Day High | $55.63 | P/E | N/A | |||
| Day Low | $55.18 | EPS | $0.00 | |||
| Volume | 9,249 | |||||
| ULTRAGENYX PHARM (NASDAQ: RARE) | Delayed: 15.61 -0.34 (2.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.95 | 52 Week High | $117.12 | |||
| Open | $15.92 | 52 Week Low | $46.52 | |||
| Day High | $15.94 | P/E | N/A | |||
| Day Low | $15.49 | EPS | $-1.97 | |||
| Volume | 896,356 | |||||
